Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis

Balint B., Kharitonov S.A., Hanazawa T., Donnelly L.E., Shah P.L., Hodson M.E., Barnes P.J.

Source: Eur Respir J 2001; 17: 1201-1207
Journal Issue: June
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Balint B., Kharitonov S.A., Hanazawa T., Donnelly L.E., Shah P.L., Hodson M.E., Barnes P.J.. Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis. Eur Respir J 2001; 17: 1201-1207

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled breath condensate: nitric oxide-related compounds
Source: Eur Respir Monogr 2010; 49: 207-216
Year: 2010


Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009



Exhaled nitric oxide is not reduced in infants with cystic fibrosis
Source: Eur Respir J 2006; 27: 350-354
Year: 2006



Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model
Source: Eur Respir J 2006; 28: 1236-1244
Year: 2006



Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC)
Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Year: 2006


Airway acidification and exhaled nitric oxide in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003

Elevated exhaled nitric oxide without acidification of exhaled breath condensate in patients with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 506s
Year: 2002

Reduced exhaled nitric oxide in infants with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Nitrite/nitrate levels in exhaled breath condensate are increased but exhaled nitric oxide levels were not in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006

Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Source: Eur Respir J 2003; 22: 457-461
Year: 2003



Superiority of hydrogen peroxide to exhaled nitric oxide as a marker of bronchial inflammation in asthmatic children
Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Year: 2008


Hydrogen peroxide in exhaled breath condensate and exhaled nitric oxide as non-invasive markers for childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009

Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings
Source: Eur Respir J 2004; 24: Suppl. 48, 157s
Year: 2004

Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006

Nasal nitric oxide, exhaled nitric oxide and exhaled breath condensate pH measurements in children with allergic disease
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms
Source: Eur Respir J 2002; 20: 841-845
Year: 2002



Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Source: Eur Respir J 2001; 17: 1267-1270
Year: 2001



Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis
Source: Eur Respir J 2002; 20: 92-99
Year: 2002